DeepMed Research

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults

Phase 4

Recruiting

Conditions: Effect of Drug

Interventions: Drug: Remimazolam

First Posted Date: 2024-03-27

Last Posted Date: 2025-05-07

Lead Sponsor: Tongji Hospital

Target Recruit Count: 165

Registration Number: NCT06333145

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Phase 2

Not yet recruiting

Conditions: Cervical Cancer
Neoadjuvant Chemoimmunotherapy
Radical Hysterectomy
Extrafascial Hysterectomy

Interventions: Drug: Cadonilimab
Drug: Paclitaxel-albumin
Drug: Cisplatin
Procedure: Extrafascial hysterectomy
Procedure: Radical hysterectomy
Procedure: Cone biopsy

First Posted Date: 2024-03-04

Last Posted Date: 2024-03-04

Lead Sponsor: Tongji Hospital

Target Recruit Count: 50

Registration Number: NCT06289751

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Phase 2

Recruiting

Conditions: Cervical Cancer
Neoadjuvant Chemoimmunotherapy
Fertility Preservation

Interventions: Drug: Camrelizumab
Drug: Cisplatin
Drug: Nab paclitaxel
Procedure: biopsy

First Posted Date: 2024-03-01

Last Posted Date: 2024-11-05

Lead Sponsor: Tongji Hospital

Target Recruit Count: 40

Registration Number: NCT06289062

Locations: 🇨🇳
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Phase 2

Recruiting

Conditions: Locally Advanced Cervical Cancer
PD-L1 Negative
Neoadjuvant Chemoimmunotherapy
Cervical Cancer

Interventions: Drug: Camrelizumab
Drug: Paclitaxel-albumin
Drug: Cisplatin
Procedure: radical surgery

First Posted Date: 2024-03-01

Last Posted Date: 2025-03-20

Lead Sponsor: Tongji Hospital

Target Recruit Count: 40

Registration Number: NCT06288360

Locations: 🇨🇳
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
🇨🇳
Beiing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, Chongqing, China

and more 9 locations

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Phase 2

Recruiting

Conditions: Cervical Cancer
Locally Advanced Cervical Cancer
Concurrent Chemoradiotherapy
Neoadjuvant Chemoimmunotherapy

Interventions: Radiation: external beam radiation therapy (EBRT) + brachytherapy
Drug: Camrelizumab
Drug: Cisplatin
Drug: Nab paclitaxel
Procedure: Radical surgery

First Posted Date: 2024-03-01

Last Posted Date: 2024-10-30

Lead Sponsor: Tongji Hospital

Target Recruit Count: 440

Registration Number: NCT06288373

Locations: 🇨🇳
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
🇨🇳
Beiing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, Chongqing, China

and more 9 locations

A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

Recruiting

Conditions: Ovarian Clear Cell Carcinoma

Interventions: Drug: immune checkpoint inhibitor based therapy
Drug: physician's choice of chemotherapy

First Posted Date: 2024-02-26

Last Posted Date: 2024-08-13

Lead Sponsor: Tongji Hospital

Target Recruit Count: 150

Registration Number: NCT06279104

Locations: 🇨🇳
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

Early Phase 1

Recruiting

Conditions: Ovarian Aging

Interventions: Drug: Yijing Keli

First Posted Date: 2024-02-22

Last Posted Date: 2024-02-22

Lead Sponsor: Tongji Hospital

Target Recruit Count: 100

Registration Number: NCT06271928

Locations: 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging

Early Phase 1

Recruiting

Conditions: Ovarian Aging

Interventions: Drug: Baozhu Keli

First Posted Date: 2024-02-13

Last Posted Date: 2024-02-13

Lead Sponsor: Tongji Hospital

Target Recruit Count: 100

Registration Number: NCT06256783

Locations: 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Ultrasound-assisted Versus Real-time Ultrasound-guided Combined Spinal-epidural Anesthesia in Elderly Patients

Not Applicable

Recruiting

Conditions: Ultrasound Therapy; Complications

Interventions: Procedure: Ultrasound-assisted localization, US-AS
Procedure: Real-time ultrasound guidance, US-RTG

First Posted Date: 2024-02-05

Last Posted Date: 2025-02-06

Lead Sponsor: Tongji Hospital

Target Recruit Count: 96

Registration Number: NCT06241716

Locations: 🇨🇳
Tianzhu Liu, Wuhan, Hubei, China

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

Phase 4

Recruiting

Conditions: Dilated Cardiomyopathy
Kaposi's Sarcoma-Associated Herpesvirus Infection

Interventions: Drug: Sirolimus

First Posted Date: 2024-02-01

Last Posted Date: 2024-02-01

Lead Sponsor: Tongji Hospital

Target Recruit Count: 276

Registration Number: NCT06236022

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy